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Edited by Lukas HuberAbstract Conﬂicting reports exist on the eﬀect of actin depoly-
merization in anti-Fas-induced apoptosis. Lysophosphatidic acid
(LPA) has been found to inhibit apoptosis in variable cell types.
In this study, we evaluated LPAs protective eﬀects on anti-Fas-
induced apoptosis enhanced by actin depolymerization and possi-
ble mechanisms in epithelial ovarian cancer. OVCAR3 cells were
pretreated with vehicle or LPA, then treated with Cytochalasin
D (Cyto D), followed with anti-Fas mAb to induce apoptosis.
Cells were stained with apoptotic markers and analyzed by ﬂow
cytometry. We report that LPA inhibited anti-Fas-induced apop-
tosis enhanced by actin depolymerization. Immunoprecipition of
Fas death-inducing signaling complex (DISC) and Western blot
suggested that the actin depolymerization accelerated caspase-8
activation, while LPA inhibited the association and activation of
caspase-8 at the DISC. LPA inhibited caspase-3 and 7 activation
induced by anti-Fas and/or Cyto D in cytosols. Phosphorylation
of ERK and Bad112 by LPA may play a role in preventing cas-
pase-3 activation through mitochondrial pathway induced by
Cyto D. Our investigation found that LPA inhibited anti-Fas-in-
duced apoptosis enhanced by actin depolymerization, and LPA
may protect epithelial ovarian cancer from immune cell attack
and cytoskeleton disrupting reagents induced apoptosis through
multiple pathways.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Apoptosis1. Introduction
Major cytoskeleton ﬁlaments, including actin, are degraded
during the execution phase of apoptosis [1]. A direct link be-
tween actin depolymerization and DNA degradation has been
suggested [2]. And there is increasing evidence that the
derangements of cytoskeleton protein actin ﬁlaments may in
themselves initiate cell death signal [3,4]. Cytochalasin D (Cyto
D), a speciﬁc inhibitor of actin polymerization, provides aAbbreviations: LPA, lysophosphatidic acid; Cyto D, Cytochalasin D;
MFI, mean ﬂuorescence index; DISC, death-inducing signaling
complex
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D has been reported to enhance cytokine withdrawal and drug
treatment-induced apoptosis [4,5]. However, conﬂicting results
exist in the eﬀect of Cyto D on anti-Fas-induced apoptosis in
diﬀerent cell types [3,4,6,7]. To date the activity of Cyto D
on anti-Fas-induced apoptosis in epithelial ovarian cancer cells
have not been studied in detail.
The cytoskeleton, together with its attached focal adhesions
and extracellular matrix forms an unique communication unit
allowing transmission of chemical signaling information into
and out of cells [8–10]. Disruption of actin ﬁlaments aﬀects
multiple cell functions including motility, signal transduction,
cell division, ultimately culminating in cell death. Cyto D, by
speciﬁcally binding to the plus end of growing actin ﬁlaments,
results in cell shape changes and the actin cytoskeleton disrup-
tion. Which synergistically enhance apoptosis induced by
DNA-damaging agents in combinational chemotherapy of
cancer [11].
Lysophosphatidic acid (LPA), the simplest form of glycero-
phospholipids, stimulates epithelial ovarian cancer cell motility
and migratory ability [12,13]. We have previously observed
LPA induced cell rounding and the actin cytoskeleton reorga-
nization. We also found that LPA signiﬁcantly inhibited anti-
Fas-induced apoptosis in epithelial ovarian cancer cells.
However, how LPA leads to epithelial ovarian cancer cell
rounding up and migration while avoiding retraction and
detachment induced apoptosis is relatively unexplored.
Dephosphorylation of Akt during cell rounding induced by
cytoskeleton disruption, accompanied by decrease bcl-2
expression and subsequent caspase activation are possible
mechanisms by Cyto D promoted apoptosis [14]. LPA stimu-
lates phosphorylation of the survival pathway ERK [15].
LPA also leads to epidermal growth factor receptor (EGFR)
signal transactivation, which plays an important role in avoid-
ing apoptosis upon detachment [16,17]. Therefore, we hypoth-
esize that LPA may function through multiple pathways to
protect epithelial ovarian cancer cell from apoptosis while
reorganizing the cytoskeleton and increasing cell motility.
Using established epithelial ovarian cancer cell lines, we
studied eﬀect of actin depolymerization on anti-Fas-induced
apoptosis. We found that non-toxic concentrations of Cyto
D enhanced anti-Fas-induced apoptosis, while LPA signiﬁ-
cantly inhibited Cyto D-enhanced anti-Fas-induced apoptosis.
LPA also inhibited caspase-3 cleavage and activation induced
by Cyto D during the early stage of apoptosis. LPA may elicit
its protective eﬀect by regulating proapoptotic protein Badblished by Elsevier B.V. All rights reserved.
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ing to the disassociation of caspase-8 at the DISC.2. Materials and methods
2.1. Cell culture and reagents
The OVCAR3 were purchased from ATCC (American Type Culture
Collection, Manassas, VA), cultured in MEM with 10% FBS, main-
tained at 37 C in a humidiﬁed atmosphere of 5% CO2, 95% air and
grown to contact-inhibited monolayer with typical cobblestone mor-
phology. Cells from each ﬂask were detached with 0.05% trypsin and
resuspended in fresh medium and cultured on glass coverslips for
immunocytochemistry studies, or on 100 mm dishes for Western blot-
ting. LPA was from Avanti Polar Lipids (Alabama). Cyto D was from
Sigma (St. Louis, MO). Anti-Fas, secondary goat anti-rabbit or anti-
mouse IgG (H + L) horseradish peroxidase conjugates were obtained
from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-phosphospec-
iﬁc ERK, anti-phosphospeciﬁc Bad antibodies were purchased from
Cell Signaling Technology (Beverly, MA). All other materials were
from Sigma unless speciﬁed.
2.2. Immunoﬂuorescence microscopy
Cells grown on coverslips to 95% conﬂuence were treated with vehi-
cles (0.1% BSA) or LPA and/or Cyto D as indicated in the ﬁgures,
rinsed twice with PBS and ﬁxed with 3.7% formaldehyde in PBS for
10 min at room temperature. Then cells were rinsed three times with
PBS and permeabilized for 5 min with 0.25% Triton X-100 prepared
in Tris-buﬀered saline containing 0.01% Tween 20 (TBST). After wash-
ing, cells were stained with Alexa Fluor 488 (1:200 dilution in blocking
buﬀer for 1 h). Actin stress ﬁbers were examined by Nikon Eclipse TE
2000-S immunoﬂuorescence microscopy with a digital camera using a
40· oil immersion objective and MetaVue software (Universal Imaging
Corp.).
2.3. Apoptosis induction and detection
After pretreatments, cells were incubated with 100 ng/ml anti-Fas
mAb (IgM) for 6 h to induce apoptosis. Cells were then harvested
and stained with annexin V-FITC and propidium iodide (PI) (BD
Pharmingen, CA), and analyzed by ﬂow cytometry (FACS, Becton
Dickinson).
2.4. Fas immunodetection
After various treatments, cells were harvested with trypsin in PBS
containing 0.5% EDTA. 2 · 105 cells were suspended in PBS contain-
ing 0.1% BSA and incubated with 500 ng/ml phycoerythrin (PE)-con-
jugated anti-human Fas DX2 IgG1 mAb (BD Pharmingen) for
30 min at 4 C. Cells were subsequently washed, resuspended in
500 ll of PBS and analyzed by FACS. Mean ﬂuorescence index
(MFI) was calculated.
2.5. Cell lysates and Western blotting
Cells were grown on 100-mm culture dishes to 95% conﬂuence. Cells
were serum starved for 2 h, treated with vehicle or LPA and/or Cyto D
in serum free media. After treatment, the reaction was stopped by rins-
ing the dishes with ice-cold PBS. Cells were lysed with 1 ml of non-
denaturing cell lysis buﬀer containing 20 mM Tris–HCl, pH 7.5,
150 mM NaCl, 1 mM Na2EDTA, 1 mM EGTA, 1% Triton, 2.5 mM
sodium pyrophosphate, 1 mM glycerophosphate, 1 mM Na3VO4,
1 lg/ml leupeptin and proteases inhibitor mixture (Roche Applied Sci-
ence), scraped, sonicated on ice with a probe sonicator (15 s · 2), and
centrifuged at 5000 · g in a microcentrifuge (4 C for 5 min). Protein
concentrations of the supernatants were determined using the Bio-
Rad protein assay kit. The supernatants, adjusted to 1 mg of pro-
tein/ml, were dissociated by boiling in 6· SDS sample buﬀer for
5 min, and samples were analyzed on 10% SDS–PAGE gels. Protein
bands were transferred onto polyvinylidene diﬂuoride (Millipore)
membranes, probed with primary and secondary antibodies according
to the manufacturers protocol, and immunodetected by using En-
hanced Chemiluminescence Kit (ECL, Amersham Biosciences). To
verify equivalent sample loading, some membranes were stripped with
stripping buﬀer for reprobing with diﬀerent antibodies.2.6. Death-inducing signaling complex (DISC) immunoprecipitation
Cells were lysed in RIPA buﬀer (30 mM Tris–HCl [pH 7.5], 150 mM
NaCl, 2 mM EDTA, 1 mM PMSF, protease inhibitor cocktail
(Roche), 1% Triton X-100 and 10% glycerol). The Fas DISC was
immunoprecipitated for 4 h at 4 C with rabbit anti-Fas antibody
and protein G plus-Agarose (Santa Cruz Biotechnology). The beads
were washed 5 times with 1 ml of RIPA buﬀer and eluted with high
base buﬀer. Western blot was performed as above with mouse mono-
clonal anti-caspase-8 and detected by the ECL detection system.
2.7. Caspase-3 and 8 colorimetric activity assay
Using Colorimetric Activity Assay Kit (Chemicon International,
Inc.). As instructed, cells lysates were incubated with caspase-3 sub-
strate (Ac-DEVD-pNA) and caspase-8 substrate (Ac-IETD-pNA) at
37 C for 4 h, and optical density (OD) values were read at 405 nm
using a spectrophotometer. Relative caspases activities were compared
with known standards and controls.
2.8. FACS analysis of intracellular protein
Cells were harvested, washed twice in PBS, then ﬁxed with 3.7%
formaldehyde in PBS for 10 min at room temperature. Then cells were
rinsed three times with PBS and permeabilized for 5 min with 0.25%
Triton X-100 prepared in TBST. After washing, cells were incubated
with primary antibodies for 30 min. After twice washing, cells were
incubated with biotin-labeled secondary antibody. After another twice
washing, cells were stained with avidin conjugated PE (BD Pharmin-
gen). Control staining for isotype binding was performed using PE-
conjugated murine immunoglobulin (Ig) G1 (BD Pharmingen). Cells
were analyzed using a FACS. To acquire data, 50 000 forward and side
light-scatter events were collected in list mode ﬁle.
2.9. Statistics
Data are expressed as means ± S.E. and analyzed by GraphPad In-
stat. Signiﬁcance was accepted at P < 0.05.3. Results
3.1. The actin cytoskeleton reorganizations induced by LPA and/
or Cyto D
LPA has been reported to induce the coordinated assembly
of focal adhesions and stress ﬁbers [18,19]. Cyto D has been
documented to lead to the F-actin depolymerization and loss
of central stress ﬁbers. We observed the actin cytoskeletonal
morphology after Cyto D and/or LPA treatments. We found
that LPA, like Cyto D, also triggered the loss of central stress
ﬁbers and focal adhesions in epithelial ovarian cancer cell line
OVCAR3, while relatively increased the peripheral actin ﬁla-
ment bundles (Fig. 1). The similar changes were observed in
Dov13 cells.3.2. LPA inhibited anti-Fas-induced apoptosis enhanced by actin
depolymerization
To investigate the eﬀect of actin depolymerization on anti-
Fas-induced apoptosis in epithelial ovarian cancer cells, we
pretreated OVCAR3 and Dov13 cells with vehicle or Cyto
D, then with anti-Fas Ab to induce apoptosis. We found that
pretreatment with Cyto D signiﬁcantly increased anti-Fas-in-
duced apoptosis (P < 0.005) (Fig. 2). To further investigate
the eﬀect of LPA on anti-Fas-induced apoptosis increased by
actin depolymerization, we initially pretreated OVCAR3 and
Dov13 cells with vehicle or LPA, then with vehicle or Cyto
D, and ﬁnally with anti-Fas Ab to induce apoptosis. We found
that LPA pretreatment before Cyto D signiﬁcantly inhibited
Cyto D-enhanced anti-Fas-induced apoptosis (§P < 0.001)
(Fig. 2).
Fig. 1. LPA and/or Cyto D induced the reorganizations of actin cytoskeleton. OVCAR3 cells grown to 95% conﬂuence were preincubated with
control vehicles or 80 lM LPA for 16 h, followed by 1 lM Cyto D or control treatment for 1 h. Cells were ﬁxed and stained with Alexa Flora dyes-
conjugated phalloidin for detection of F-actin cytoskeletal organization using immunoﬂuorescence microscopy at an 40· oil objective.
Fig. 2. LPA inhibits Cyto D-enhanced anti-Fas-induced apoptosis. OVCAR3 and Dov13 cells were pretreated with vehicle or 80 lM LPA for 16 h,
then pretreated with vehicle or 1 lM Cyto D for 1 h, cells were incubated with anti-Fas Ab for 6 h to induce apoptosis. Cells were harvested and
stained with PI and Annexin V-FITC and analyzed by FACS. (A) One of the FACS results from OVCAR3 cells. (B) In both OVCAR3 and Dov13
cells, *P < 0.05, anti-Fas Ab treatment induced apoptosis compare to control; P < 0.05 LPA inhibited anti-Fas-induced apoptosis; P < 0.05 anti-
Fas-induced apoptosis enhanced by Cyto D compare to anti-Fas Ab only; §P < 0.001 LPA pretreatment before Cyto D signiﬁcantly inhibited Cyto D
augmented anti-Fas-induced apoptosis. Data are shown as mean values ± S.E.M. of three independent and reproducible experiments.
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Fig. 3. Eﬀect of LPA and/or Cyto D on Fas cell surface presentation.
OVCAR3 and Dov13 cells were pretreated with vehicle or LPA for 16
h, then with vehicle or Cyto D for 1 h, the cell surface Fas presentation
were assayed by FACS. MFI was calculated. *P < 0.05, LPA
pretreatment compared with control; P > 0.05 CytoD treatment
compared with control; P < 0.05 LPA pretreatment before CytoD
treatment compared with CytoD treatment alone; Data shown are
mean values ± S.E.M. of 3–5 independent and reproducible
experiments.
1314 Y. Meng et al. / FEBS Letters 579 (2005) 1311–13193.3. LPA downregulates Fas presentation on the ovarian cancer
cell surface
To observe the eﬀect of LPA/CytoD onFas expression on the
cell surface, we incubated OVCAR3 and Dov13 cells with LPA
for 16 , then with CytoD for another 1 h, and Fas cell surface
presentation was immunodetected by FACS. We found thatFig. 4. LPA inhibited caspase-8 activation induced by anti-Fas and/or by
agarose with rabbit anti-Fas, immunoblotted with mouse monoclonal anti-ca
incubated with caspase-8 substrate (Ac-IETD-pNA) at 37 C for 4 h, and
compared with known standards and controls. Data shown are mean valuestreatment of ovarian cancer cells with LPA signiﬁcantly inhib-
ited Fas cell surface presentation (Fig. 3). However, Cyto D
did not have a signiﬁcant role in Fas cell surface presentation.
3.4. LPA inhibited caspase-8 activation induced by anti-Fas and
Cyto D
Caspase-8 has been reported to be the most proximal to the
original signals in the initial stages of Fas-mediated apoptosis
[20–22]. Cyto D treatment may lead to caspase-8 cleavage and
activation [3,23]. However, there is no information regarding
the eﬀect of LPA on its regulation. We pretreated OVCAR3
cells with vehicles or LPA, then Cyto D, and induced apoptosis
with anti-Fas Ab for 1 h, cells lysates were immunoprecipited
for Fas DISC and the associations of caspase-8 with the DISC
was observed (Fig. 4A). We found that by Western blot Cyto
D induced slight cleavage of caspase-8 at the DISC (lane 3
compared to control lane 1). Anti-Fas also induced caspase-8
accumulation at the DISC (lane 5 compared to control lane
1). Cyto D pretreatment signiﬁcantly accelerated caspase-8
cleavage and activation at the DISC (lane 7 compared to lane
5). There were less caspase-8 associations at the DISC after
LPA treatments, all in the control LPA treatment (lane 2 com-
pared to lane 1), LPA pretreatment before anti-Fas (lane 6
compared to lane 5), and LPA pretreatment before Cyto D
and anti-Fas (lane 8 compared to lane 7). Also there were sig-
niﬁcantly less activation or cleavage after LPA pretreatment
before Cyto D and anti-Fas (lane 8 compared to lane 7).
The same results were achieved in repeated experiments per-
formed using the Dov13 cells.Cyto D. (A) Cell lysates were immunoprecipited with protein G plus
spase-8, and detected by the ECL. (B) Cell lysates treated as above were
OD values were read at 405 nm. Relative caspase-8 activities were
± S.E.M. of 3–5 independent and reproducible experiments.
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ties were quantiﬁed by a colorimetric activity assay (Fig. 4B).
Compared to control vehicle Cyto D signiﬁcantly increased
caspase-8 activity (*P < 0.05). Anti-Fas also signiﬁcantly in-
creased caspase-8 activity (P < 0.01). Cyto D pretreatment
had additive activity in anti-Fas-induced caspase-8 activity
(P < 0.05). However, LPA pretreatment before Cyto D signif-
icantly inhibited anti-Fas-induced caspase-8 activity that was
enhanced by Cyto D (§P < 0.01).3.5. LPA inhibited caspase-3 and 7 activation induced by
anti-Fas and Cyto D
Following activation of the initiator caspases, downstream
eﬀector caspases may be activated in turn to cleave critical cel-
lular protein substrates leading to the systematic dismantling
of the cell [24–26]. We further studied the eﬀect of LPA on cas-
pase-3 and caspase-7 activation induced by Cyto D and anti-
Fas. Cells treated as above for 5 h were lysed and cytosols were
collected and caspase-3 and 7 cleavage and activation were ob-
served (Fig. 5A). We found Cyto D itself induced cleavage and
activation of caspase-3 (lane 3 compared to control lane 1).
Anti-Fas alone induced caspase-3 cleavage and activation
(lane 4 compared to control lane 1). Cyto D pretreatment
accelerated caspase-3 cleavage to the lowest molecular form,
from 17/15 to 15/11 kDa (lane 6 compared to control lane 4).
There were less caspase-3 cleavage or activation after LPA
treatments, LPA pretreatment before anti-Fas (lane 5 com-
pared to lane 4), and LPA pretreatment before Cyto D and
anti-Fas (lane 7 compared to lane 6). LPA pretreatment also
inhibited caspase-7 cleavage or activation induced by anti-
Fas (lane 5 compared to lane 4, and lane 7 compared to lane
6). Cyto D pretreatment slightly increased caspase-7 cleavage
and activation induced by anti-Fas (lanes 6, 7 compared to
lane 4, 5), but did not have a direct eﬀect on caspase-7 activa-
tion (lane 3). The same results were seen in experiments per-
formed using Dov13 cells.
To conﬁrm the direct inhibiting role of LPA on caspase-3
cleavage and activation, cells were pretreated with diﬀerent
doses of LPA, then treated with Cyto D. Western blot found
that LPA in a dose-dependent manner inhibited caspase-3
cleavage and activation (Fig. 5B). Colorimetric caspase-3
activity assay (Fig. 5C) conﬁrmed that Cyto D alone activated
caspase-3 (*P < 0.05 compared to control vehicle), anti-Fas-in-
duced caspase-3 activation (P < 0.01), while Cyto D signiﬁ-
cantly added more caspase-3 activity induced by anti-Fas
(P < 0.05). LPA pretreatment before Cyto D signiﬁcantly
inhibited the anti-Fas-induced caspase-3 activity enhanced by
Cyto D (§P < 0.01).3.6. Eﬀect of LPA and/or Cyto D on ERK and Bad
phosphorylation
LPA stimulates the survival signal ERK phosphorylation
through EGFR transactivation [15,16], and may also induce
activation of PI3/Akt signaling [27,28]. Activation of ERK
may lead to the proapoptotic protein Bad phosphorylation
at Ser112 [29], while activation of PI3/Akt could lead to phos-
phorylation of Bad at Ser136 [30,31]. Phosphorylation of Bad
can displace Bax from binding to Bcl-2 and Bcl-XL thus pre-
venting cells undergoing apoptosis through mitochondrial
pathway [29,31,32]. To investigate the eﬀect of LPA and/or
Cyto D on ERK and Bad phosphorylation, we permeabilizedcells and intracellularly stained ERK and Bad with phosphor-
ylation speciﬁc antibodies. FACS showed that Cyto D did not
have a signiﬁcant role on ERK phosphorylation, but indeed
inhibited Bad phosphorylation at Ser136 (Fig. 6A). LPA treat-
ment induced signiﬁcant ERK phosphorylation and Bad phos-
phorylation at Ser112 (Fig. 6B and C). LPA pretreatment,
however, prevented Bad136 dephosphorylation induced by
Cyto D (Fig. 6D). ERK phosphorylation and activation may
prevent the downregulation of PI3/Akt signaling induced by
Cyto D. The same experiments were repeated in both OV-
CAR3 and Dov13 cells and similar results were achieved.4. Discussion
Anti-Fas treatment stimulated rapid assembly of F-actin and
subsequent caspase-dependent apoptosis arguing that actin
polymerization is required for the induction of apoptosis
[33]. While others have demonstrated that actin depolymeriza-
tion either does not aﬀect or enhance anti-Fas-induced apopto-
sis [3,4], we found that actin depolymerization by Cyto D
sensitized epithelial ovarian cancer cells to anti-Fas-induced
rapid apoptosis, suggesting that the actin cytoskeleton may
play diﬀerent roles in induction of apoptosis in fundamentally
diﬀerent cell types.
Akt has been implicated in several cytoskeleton-mediated
processes including apoptosis [14,34,35]. We did not observe
signiﬁcant Akt activation, nor Bcl-2 expression change in
LPA treated epithelial ovarian cancer cells (data not shown),
though the cooperative control of Akt phosphorylation and
bcl-2 expression have been suggested to play a role in apopto-
sis induced by cytoskeletal disruption or extracellular matrix
turnover and cell shape changes [14]. However, we did ﬁnd
strong ERK phosphorylation minutes after LPA stimulation.
ERK activation may eﬃciently counteract apoptosis induced
by disruption of the actin cytoskeleton [36–38]. In the parallel
experiment, we conﬁrmed Bad phosphorylation at Ser112 and
LPA pretreatment also prevented the dephosphorylation of
Bad at Ser136 induced by Cyto D. This suﬃcient phosphory-
lation of Bad may regulate the ratios of the anti-apoptotic pro-
tein Bcl-2/Bcl-XL to the pro-apoptotic protein Bad/Bax, and
subsequently inhibit caspase-3 activation and cytochrome c re-
lease from mitochondria [29,32,39,40].
Caspase-3 was activated during actin depolymerization in-
duced by Cyto D, which may be one mechanism how Cyto
D enhances anti-Fas-mediated rapid apoptosis. In addition,
caspase-8, the initiator caspase involved in regulating Fas-
mediated apoptosis, was also activated during actin cytoskele-
tonal disruption in epithelial ovarian cancer. This ﬁnding is
consistent with Rytomma et al. [41]. Non-toxic concentrations
of Cyto D may accelerate anti-Fas-mediated apoptosis
through both mitochondrial and Fas receptor pathways, which
may account for the greater levels of apoptosis observed by
Cyto D pretreatment. Although, we did not see signiﬁcant
apoptosis quickly after Cyto D treatment, caspase activations
had already began. LPA pretreatment lead to less association
of caspase-8 with DISC and decreased its subsequent cleavage
and activation. Together with the eﬃcient phosphorylation of
ERK and Bad prevented caspase-3 activation and cytochrome
c release from mitochondria. Thus LPA prevents anti-Fas-
mediated apoptosis enhanced by Cyto D also through both
Fig. 5. LPA inhibited caspase-3 and 7 activation induced by anti-Fas, also caspase-3 activation by Cyto D. (A) OVCAR3 cells were pretreated LPA,
Cyto D and induced apoptosis with anti-Fas Ab for 5 h, cells lysates subject to western blot for caspase-3 and 7 detection. (B) Cells were pretreated
with diﬀerent doses of LPA, and then treated with Cyto D, Western blot proved that LPA dose dependent inhibited caspase-3 activation. (C)
Caspase-3 colorimetric activity assay: cell lysates treated as above were incubated with caspase-3 substrate (Ac-DEVD-pNA) at 37 C for 4 h, and
OD values were read at 405 nm. Relative caspase-3 activities were compared with known standards and controls. Data shown are mean
values ± S.E.M. of 3–5 independent and reproducible experiments.
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explain why LPA induced epithelial ovarian cancer cell round-
ing up and cytoskeletal rearrangements, ready to migrate,
while keeping cells from detachment induced apoptosis [12].Actin and the actin-associated proteins have been shown to
be cleaved during apoptosis [2,42]. The cytoskeleton may reg-
ulate membrane bleb formation in the execution phase of
apoptosis [43,44]. Our studies suggest that the cytoskeletal
Fig. 6. LPA induced ERK and Bad112 phosphorylation. OVCAR3 cells were pretreated LPA for 16 h, then Cyto D was added for another 6 h. Cells
were ﬁxed and permeabilized, incubated with primary antibodies for 30 min, then with biotin labeled secondary antibody for 30 min, and then with
avidin conjugated PE for 30 min. Cells were washed and analyzed by FACS. Control staining for isotype binding was performed using PE-
conjugated mouse immunoglobulin (Ig). (A) Data shown as one of the representatives of FACS. Broken lines are isotype controls and solid lines are
speciﬁc Ab staining. (B–D) Artiﬁcial gates were set and intracellular positive staining cells were counted. For pERK and pBad112, *P < 0.01, LPA
pretreatment compared with control; P > 0.05 CytoD treatment compared with control; P < 0.01 LPA pretreatment before CytoD treatment
compared with CytoD treatment alone; for pBad136, *P < 0.05, LPA pretreatment compared with control; P < 0.05 CytoD treatment compared
with control; P < 0.05 LPA pretreatment before CytoD treatment compared with CytoD treatment alone; Data shown are mean values ± S.E.M of
3–5 independent and reroducible experiments.
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the apoptosis signal transduction cascade in epithelial ovarian
cancer. Cytoskeletal reorganization and/or disruption leads to
apoptosis in a variety of cell types [45–47]. Additionally, we
further investigated the anti-Fas-mediated apoptosis enhanced
by actin depolymerization, and how LPA may prevent anti-
Fas-mediated apoptosis enhanced by Cyto D through both
mitochondrial and Fas signaling pathways. Our research sup-
ports the idea that the cytoskeleton plays a role in both the
induction and execution phase of the apoptosis, and LPA
may accelerate epithelial ovarian cancer metastasis by inhibit-
ing both Fas/FasL-mediated and cytoskeletal disruption-in-
duced apoptosis.5. Conclusion
The cytoskeleton disrupting reagent, Cyto D, enhanced anti-
Fas-induced apoptosis while inducing actin depolymerization.
LPA, though lead to signiﬁcant cytoskeleton reorganizations,
protect epithelial ovarian cancer from anti-Fas-induced apop-
tosis enhanced by Cyto D. The actin depolymerization by Cyto
D accelerated the cleavage and activation of initiator caspase-8
at the DISC and the eﬀector caspase-3 activation in the cyto-
sol. To counteract it, LPA decreased the association and acti-vation of caspase-8 at the DISC, and inhibited the activation
of caspase-3 and 7 in the cytosol. Phosphorylation of ERK
and Bad112 by LPA may play a direct role in preventing the
caspase-3 activation induced by Cyto D through the mitochon-
drial pathway. Downregulation of Fas on the cell surface and
disassociation of caspase-8 at the DISC by LPA also inhibited
Fas signaled apoptosis. Thus LPA eﬃciently inhibits anti-Fas-
mediated apoptosis enhanced by the actin depolymerization
through both mitochondrial and Fas signaling pathways. Elu-
cidation of how LPA leads to the disassociation of caspase-8
with the membrane DISC will contribute to our understanding
of the function of the cytoskeletal-plasma membrane linker
proteins in apoptosis. Above all this study suggests that the ac-
tin cytoskeleton may be an early modulator of apoptotic com-
mitment, and multiple signal pathways are involved in cell
motility and apoptosis regulations. LPA may protect ovarian
cancer cells from immune cell attack and cytoskeleton disrupt-
ing chemotherapeutics induced apoptosis at multiple signal
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